|
KMID : 1234520160110030077
|
|
Korean Journal of Urogenital Tract Infection Inflammation
2016 Volume.11 No. 3 p.77 ~ p.85
|
|
|
Antimicrobial Prophylaxis in Urological Surgery
|
|
Yamamoto Shingo
Shigemura Katsumi
Kiyota Hiroshi
Arakawa Soichi
Japanese Research Group for UTI
|
|
|
Abstract
|
|
|
|
Surgical site infection (SSI) is defined as an infection occurring within one month from surgery or intervention. SSIs are classified into three categories: Clean, clean-contaminated, and contaminated. They are defined as procedures that avoid entering the urinary tract, involve entry of the urinary tract, and involve the bowels, respectively. The purpose of antimicrobial prophylaxis (AMP) is to protect the surgical wound from contamination by normal bacterial flora. AMP should be based on penicillin with beta-lactamase inhibitors, or first- or second-generation cephalosporins. Broad-spectrum antimicrobials, such as third- and fourth-generation cephalosporins or carbapenems, should be used to treat postoperative infections but not AMP. AMP should be started no less than 30 minutes prior to the start of the operation. AMP should be administered by a single dose or be terminated within 24 hours in cases of transurethral, clean, or clean-contaminated surgery, and within 2 days in cases of bowl (contaminated) surgery. These guidelines are applicable preoperatively only for non-infected, low-risk patients. The risk of patients for infection should be evaluated preoperatively, such as with a urine culture test. In cases with preoperative infection or bacteriuria that can cause an SSI or urinary tract infection following surgery, patients must receive adequate preoperative treatment based on their individual situation.
|
|
|
KEYWORD
|
|
|
Surgical wound infection, Antimicrobial prophylaxis, Urological surgery
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|